702 related articles for article (PubMed ID: 1646506)
1. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Hess AD; Bright EC
Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
[TBL] [Abstract][Full Text] [Related]
2. Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
Esa AH; Boto WO; Adler WH; May WS; Hess AD
Int J Immunopharmacol; 1990; 12(5):481-90. PubMed ID: 2210911
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine inhibits T-cell activation at two distinct levels: role of the CD 28 activation pathway.
Hess AD; Bright EC
Transplant Proc; 1991 Feb; 23(1 Pt 2):961-6. PubMed ID: 1846483
[No Abstract] [Full Text] [Related]
4. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells.
Osorio LM; Rottenberg M; Jondal M; Chow SC
Immunology; 1998 Mar; 93(3):358-65. PubMed ID: 9640246
[TBL] [Abstract][Full Text] [Related]
6. Activation of human T lymphocytes by bryostatin.
Hess AD; Silanskis MK; Esa AH; Pettit GR; May WS
J Immunol; 1988 Nov; 141(10):3263-9. PubMed ID: 3263418
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation.
Chong AS; Finnegan A; Jiang X; Gebel H; Sankary HN; Foster P; Williams JW
Transplantation; 1993 Jun; 55(6):1361-6. PubMed ID: 8390735
[TBL] [Abstract][Full Text] [Related]
8. Evidence that genistein, a protein-tyrosine kinase inhibitor, inhibits CD28 monoclonal-antibody-stimulated human T cell proliferation.
Atluru S; Atluru D
Transplantation; 1991 Feb; 51(2):448-50. PubMed ID: 1847252
[TBL] [Abstract][Full Text] [Related]
9. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
Carabasi MH; DiSanto JP; Yang SY; Dupont B
Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
[TBL] [Abstract][Full Text] [Related]
10. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes.
Härtel C; Hammers HJ; Schlenke P; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
J Interferon Cytokine Res; 2003 Feb; 23(2):91-9. PubMed ID: 12744774
[TBL] [Abstract][Full Text] [Related]
11. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.
June CH; Ledbetter JA; Gillespie MM; Lindsten T; Thompson CB
Mol Cell Biol; 1987 Dec; 7(12):4472-81. PubMed ID: 2830495
[TBL] [Abstract][Full Text] [Related]
12. Effects of the protein kinase C stimulant bryostatin 1 on the proliferation and colony formation of irradiated human T-lymphocytes.
Sung SJ; Lin PS; Schmidt-Ullrich R; Hall CE; Walters JA; McCrady C; Grant S
Int J Radiat Biol; 1994 Dec; 66(6):775-83. PubMed ID: 7814976
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation by dexamethasone and cyclosporine of human T cells activated by various stimuli.
Furue M; Ishibashi Y
Transplantation; 1991 Sep; 52(3):522-6. PubMed ID: 1654606
[TBL] [Abstract][Full Text] [Related]
14. CD7 augments T cell proliferation via the interleukin-2 autocrine pathway.
Jung LK; Roy AK; Chakkalath HR
Cell Immunol; 1992 Apr; 141(1):189-99. PubMed ID: 1372842
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of antibodies to CD3 surface antigen and phytohemagglutinin-mediated T cellular responses by inhibiting Ca2+/phospholipid-dependent protein kinase activity with the aid of 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine dihydrochloride.
Nel AE; Schabort I; Rheeder A; Bouic P; Wooten MW
J Immunol; 1987 Oct; 139(7):2230-6. PubMed ID: 2821109
[TBL] [Abstract][Full Text] [Related]
16. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
Lin CS; Boltz RC; Siekierka JJ; Sigal NH
Cell Immunol; 1991 Apr; 133(2):269-84. PubMed ID: 1707760
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
[TBL] [Abstract][Full Text] [Related]
18. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
Levine BL; May WS; Tyler PG; Hess AD
J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
[TBL] [Abstract][Full Text] [Related]
19. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.
Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL
Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266
[TBL] [Abstract][Full Text] [Related]
20. Two distinct mechanisms of interleukin-2 gene expression in human T lymphocytes.
June CH; Jackson KM; Ledbetter JA; Leiden JM; Lindsten T; Thompson CB
J Autoimmun; 1989 Jun; 2 Suppl():55-65. PubMed ID: 2550020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
